INNOVA CAPTAB
|
The Current P/E Ratio of INNOVA CAPTAB is 38.95.
Share Price | ₹873.3 | Jun 11,2025 |
Market Cap | ₹4,995.3 Cr | |
Earnings-TTM | ₹128.3 Cr | TTM-Consolidated Results |
Price/Earnings | 38.95x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of INNOVA CAPTAB
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹4,995.3 Cr] as on Jun 11,2025
(/) Earnings [ ₹128.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 38.95x ]
Thus, for INNOVA CAPTAB , the investors are currently willing to pay 38.95 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INNOVA CAPTAB !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of INNOVA CAPTAB over the last five years.
Historical PE (Price/Earnings) ratio chart of INNOVA CAPTAB
PE Ratio Performance Analysis for INNOVA CAPTAB
- INNOVA CAPTAB 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 5.44x.
- INNOVA CAPTAB 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INNOVA CAPTAB 's p/e ratio peaked in Mar2024 at 27.18x.
- INNOVA CAPTAB 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does INNOVA CAPTAB 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
INNOVA CAPTAB | 128.26 | 38.95 | 4,995.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.96 | 405,824.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 81.40 | 178,355.0 |
CIPLA LTD | 5,291.05 | 23.23 | 122,929.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 56.78 | 108,502.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 19.76 | 112,701.0 |
MANKIND PHARMA LTD | 2,003.22 | 49.00 | 98,151.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.34 | 98,485.1 |
LUPIN LTD | 3,306.26 | 28.01 | 92,597.3 |
AUROBINDO PHARMA LTD | 3,515.26 | 19.17 | 67,381.7 |
ABBOTT INDIA LTD | 1,414.44 | 47.51 | 67,196.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INNOVA CAPTAB 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.17x |
Max industry PE | 81.40x |
Median industry PE | 36.96x |
Average industry PE | 38.37x |
You may also like the below Video Courses